stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Total debt
Teleflex Incorporated's total debt at the end of fiscal 2025 was $2.6B, up 59.5% from $1.7B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $2.8B. Over the past ten years it has ranged from $1.0B (fiscal 2016) to $2.6B (fiscal 2025) — the current reading is the highest in ten years. Teleflex Incorporated ranks 7th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $2.6B | 59.52% |
| FY2024 | $1.7B | (8.77%) |
| FY2023 | $1.8B | 6.05% |
| FY2022 | $1.7B | (7.49%) |
| FY2021 | $1.9B | (25.35%) |
| FY2020 | $2.5B | 29.83% |
| FY2019 | $1.9B | (11.57%) |
| FY2018 | $2.2B | (4.03%) |
| FY2017 | $2.2B | 117.32% |
| FY2016 | $1.0B | (2.27%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $2.8B | 7.28% |
| Mar 2026 | $2.6B | (0.91%) |
| Dec 2025 | $2.6B | (1.13%) |
| Sep 2025 | $2.7B | 40.48% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| TFX Teleflex Incorporated | $2.8B |
| NVST Envista Holdings Corporation compare | $1.4B |
| ATR AptarGroup, Inc. compare | $1.4B |
| ICUI ICU Medical, Inc. compare | $1.2B |
| MMSI Merit Medical Systems, Inc. compare | $737.4M |
| PLSE Pulse Biosciences, Inc compare | $9.4M |
| MMED MiniMed Group, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement